tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Le Berrigaud, 2 are a HOLD (25%), 6 are a BUY (75%).
Analyst Eric Le Berrigaud, currently employed at STIFEL, carries an average stock price target met ratio of 13.33% that have a potential upside of 2.64% achieved within 53 days.
Eric Le Berrigaud’s has documented 24 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 07-Jul-2024.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 12/5/2022. The price target of $95 was fulfilled within 121 days with a profit of $7.83 (8.98%) receiving and performance score of 0.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$58
$6.36 (12.32%)
$55
1 months 23 days ago
(07-Sep-2025)
1/11 (9.09%)
$11.2 (23.93%)
224
Buy
$82.72
1 months 29 days ago
(01-Sep-2025)
0/13 (0%)
$47.73 (136.41%)
Hold
10 months 28 days ago
(02-Dec-2024)
0/7 (0%)
$55.97 (133.04%)
Buy
$60
$8.36 (16.19%)
$60
1 years 3 months 5 days ago
(25-Jul-2024)
0/2 (0%)
$9.82 (19.57%)
Buy
$101.24
1 years 3 months 23 days ago
(07-Jul-2024)
0/2 (0%)
$60.03 (145.67%)
What Year was the first public recommendation made by Eric Le Berrigaud?
